• Skip to primary navigation
  • Skip to main content
AMRA MedicalAMRA Medical

AMRA Medical

Precision for Decision

  • Career
  • Support
  • Contact Us
  • Solutions
    • Clinical Services
    • Research Services
  • Get Set Up
    • Get Set Up
    • Get a Quote
  • Science
    • What We Do
    • How We Do It
    • Why It Matters
    • Our Core Areas
    • Technology
  • News & Events
    • News
    • Events
  • Resources
    • Webinars
    • Publications
    • Whitepapers
    • Media
  • About Us
    • About AMRA
    • Our Team
    • Partners & Investors
  • Career
  • Support
  • Contact Us

New Study Reveals Method Linking AMRA Medical’s Muscle Biomarkers and Function

October 23, 2019
  • Facebook
  • Twitter
  • LinkedIn
  • Mail

Enhances link between muscle-specific characteristics to function by leveraging UK Biobank data and MR imaging technology.

LINKÖPING, Sweden; October 23, 2019 – A new study published by authors from AMRA Medical, Linköping University and Pennington Biomedical Research Center in Journal of Gerontology: Medical Sciences on October 23, 2019 unveils a novel method for combined assessment of muscle quantity and fat infiltration to identify individuals with low functional performance using data from the UK Biobank.

Sarcopenia is characterized by gradual loss of muscle mass and function and is associated with disease-related complications that can be devastating to the patient and increase the healthcare burden. Accurately assessing sarcopenia is difficult due to muscle volume and function being influenced by several factors such as age, weight, fitness, pain and disease. Healthcare professionals agree that measuring muscle function and quantity is necessary to accurately assess and confirm sarcopenia, but methods to adjust muscle quantity for body size varies and functional measures lack muscle-specificity and sensitivity to root cause.

In the study, it was suggested that to enable physicians to deliver the best possible care, combined muscle assessments must be adjusted to account for confounding factors, such as obesity, and be used throughout the course of the disease. Current sarcopenia definitions show decreased sarcopenia prevalence with increasing BMI. But contrarily, as BMI increases, functional performance declines, demonstrating the need for BMI-independent measures. Additionally, some patients are unable to perform certain muscle function assessments (e.g. hand grip strength, stair climbing, walking pace), keeping clinicians in the dark as disease progresses. Objective muscle-biomarkers linked to function could expand the toolbox clinicians use to assess sarcopenia with heightened precision.

The authors used MRI-based body composition analysis to simultaneously quantify fat-free muscle volume and muscle fat infiltration of 9,615 participants in the UK Biobank imaging sub-study, each sex-and-BMI-matched with an individualized virtual control group – an innovative control. To assess the clinical value of the combined method for sarcopenia, associations with hand grip strength, walking pace, stair climbing, falls, and health care burden were compared with separate evaluations using either fat-free muscle volume or muscle fat infiltration.

Key Findings from the study:

  • Hospital nights, low hand grip strength, slow walking pace, lack of stair climbing, and number of falls were positively associated with muscle fat infiltration and most were negatively associated with fat-free muscle volume.
  • Fat-free muscle volume and muscle fat infiltration combined showed the highest diagnostic performance for detecting low function
  • Virtual control group-adjusted muscle volume normalized BMI enabled accurate muscle assessment across BMI-classes.

Combining fat-free muscle volume with muscle fat infiltration and incorporating virtual control groups increased diagnostic performance for detecting low muscle function and adjusts for BMI. This method can potentially serve as a framework for clinicians and researchers to objectively detect sarcopenia using quantifiable MR imaging biomarkers. Furthermore, this combinatorial approach could potentially be utilized throughout the life of a patient, when they are unable to perform physical functionality tests. Lastly, this method could serve as a standardized approach, enabling cross-study comparisons, to further the field of sarcopenia research leading to better treatment for patients.

UK Biobank has already imaged almost 50,000 participants and is planning to double that number in the next three years. Professor Rory Collins, UK Biobank Principal Investigator, said: “It is encouraging to see important work like this being generated on body images of 10,000 UK Biobank participants. As the technology to do this type of research improves,  we anticipate further exciting advances that will help scientists find ways to ensure we live healthier lives for longer.”​

Full publication in Journal of Gerontology: 

Linge J. et al, (2019) On the Definition of Sarcopenia in the Presence of Aging and Obesity – Initial Results from UK Biobank, Journal of Gerontology: Medical Sciences

___________________________________________________________________________________

 

About AMRA Medical

AMRA (www.amramedical.com) is a groundbreaking international digital health company at the forefront of medical imaging and precision medicine. The company has developed a new global standard in body composition assessment, the ability to automatically produce multiple fat and muscle biomarkers with unrivaled precision and accuracy, as well as contextual disease insights – all from a single, rapid, whole-body MRI. AMRA was founded in 2010 as a spin-off of Linköping University, Sweden, with the aim to support transformative care and vital decision-making from clinical research to health and wellness.

Contact:
Rosemary Shull
SVP Global BD & Marketing
rosemary.shull@amramedical.com

 

About UK Biobank

UK Biobank (www.ukbiobank.ac.uk) is a major national and international health resource with the aim of improving the prevention, diagnosis and treatment of a wide range of serious and life-threatening illnesses. In 2006-2010, UK Biobank recruited 500,000 people between the ages of 40–69 years old from across the country. The project has permission to follow participants’ health through medical records. UK Biobank has also embarked on a major project to MRI scan the vital internal organs and body composition of 100,000 participants. Over many years, these detailed data will build a powerful resource to help scientists discover why some people develop particular diseases and others do not, and to suggest new ways of preventing and treating them.

Contact:
Andrew Trehearne
Head of Communications
andrew.trehearne@ukbiobank.ac.uk

All posts
  • Facebook
  • Twitter
  • LinkedIn
  • Mail
AMRA Medical
Follow us

About

AMRA offers clinical services and research services to support transformative care and vital decision-making, from clinical research to clinical care.

  • Data Privacy Policy
  • Cookie Policy

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Contact

  • info@amramedical.com
  • +46 (0) 13 16 26 00
  • Contact Our Support

Newsletter

© 2025 AMRA Medical AB
AMRA Medical
Manage Cookie Consent
To provide the best experiences, we use technologies like cookies to store and/or access device information. Consenting to these technologies will allow us to process data such as browsing behavior or unique IDs on this site. Not consenting or withdrawing consent, may adversely affect certain features and functions.
Functional Always active
The technical storage or access is strictly necessary for the legitimate purpose of enabling the use of a specific service explicitly requested by the subscriber or user, or for the sole purpose of carrying out the transmission of a communication over an electronic communications network.
Preferences
The technical storage or access is necessary for the legitimate purpose of storing preferences that are not requested by the subscriber or user.
Statistics
The technical storage or access that is used exclusively for statistical purposes. The technical storage or access that is used exclusively for anonymous statistical purposes. Without a subpoena, voluntary compliance on the part of your Internet Service Provider, or additional records from a third party, information stored or retrieved for this purpose alone cannot usually be used to identify you.
Marketing
The technical storage or access is required to create user profiles to send advertising, or to track the user on a website or across several websites for similar marketing purposes.
Manage options Manage services Manage {vendor_count} vendors Read more about these purposes
View preferences
{title} {title} {title}
AMRA Medical
Manage Cookie Consent
To provide the best experiences, we use technologies like cookies to store and/or access device information. Consenting to these technologies will allow us to process data such as browsing behavior or unique IDs on this site. Not consenting or withdrawing consent, may adversely affect certain features and functions.
Functional Always active
The technical storage or access is strictly necessary for the legitimate purpose of enabling the use of a specific service explicitly requested by the subscriber or user, or for the sole purpose of carrying out the transmission of a communication over an electronic communications network.
Preferences
The technical storage or access is necessary for the legitimate purpose of storing preferences that are not requested by the subscriber or user.
Statistics
The technical storage or access that is used exclusively for statistical purposes. The technical storage or access that is used exclusively for anonymous statistical purposes. Without a subpoena, voluntary compliance on the part of your Internet Service Provider, or additional records from a third party, information stored or retrieved for this purpose alone cannot usually be used to identify you.
Marketing
The technical storage or access is required to create user profiles to send advertising, or to track the user on a website or across several websites for similar marketing purposes.
Manage options Manage services Manage {vendor_count} vendors Read more about these purposes
View preferences
{title} {title} {title}